This CPB has been revised to state that the following are considered experimental and investigational: (i) Biophotonic Therapy; (ii) Buteyko breathing technique, (iii) glutathione infusion for chemotherapy-induced neuropathy, chronic fatigue syndrome, common variable immune deficiency, contrast media-induced nephropathy, and functional diarrhea, (iv) salt room therapy, and (v) vibro-acoustic therapy. This CPB is revised to state that medical marijuana is not covered because it is not an FDA-approved prescription medication.